Literature DB >> 12836164

Characterisation of a sphingosine 1-phosphate-activated Ca2+ signalling pathway in human neuroblastoma cells.

Israel Ramos Villullas1, Alison J Smith, Robert P Heavens, Peter B Simpson.   

Abstract

Sphingosine 1-phosphate (S1P) has assumed great importance within neuroscience research because of putative links between S1P-sensitive Edg receptors and neuroregeneration, cell survival, and alterations in neurite outgrowth. In the present study, we examined the mechanisms by which the endogenous complement of S1P-sensitive human Edg receptors can elevate Ca(2+) in the human neuroblastoma cell line, SH-SY5Y. Reverse transcriptase-polymersase chain reaction (RT-PCR) confirmed the expression of mRNA for Edg 3, 5, and 8 subtypes of S1P-responsive Edg receptors in SH-SY5Y cells. Neither S1P nor the muscarinic agonist methacholine were able to cause a change in SH-SY5Y cell morphology, whereas retinoic acid caused a range of changes, including an increase in neurite outgrowth, under similar test conditions. Stimulation with S1P resulted in a slowly rising increase in cytosolic Ca(2+) levels. These responses were dependent upon inositol-1,4,5-trisphosphate receptors, thapsigargin-sensitive endoplasmic reticulum, and also intact functional mitochondria. S1P-evoked Ca(2+) responses were similar in mechanism to those of methacholine, which activated a much faster responding, larger amplitude Ca(2+) response. These studies indicate that in an endogenous human expression system, S1P appears to be an efficacious agonist of Edg receptors. Despite its slow time course of response, S1P appears to activate the same single Ca(2+) store in SH-SY5Y cells as is activated by methacholine and other G protein coupled receptors. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12836164     DOI: 10.1002/jnr.10636

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  4 in total

1.  Sphingosine-1-phosphate and calcium signaling in cerebellar astrocytes and differentiated granule cells.

Authors:  Paola Giussani; Anita Ferraretto; Claudia Gravaghi; Rosaria Bassi; Guido Tettamanti; Laura Riboni; Paola Viani
Journal:  Neurochem Res       Date:  2006-12-07       Impact factor: 3.996

2.  Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1.

Authors:  Franck Talmont; Lionel Moulédous
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-01-24       Impact factor: 3.000

3.  Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway.

Authors:  Piming Zhao; Ana E Aguilar; Joanna Y Lee; Lucy A Paul; Jung H Suh; Latika Puri; Meng Zhang; Jennifer Beckstead; Andrzej Witkowski; Robert O Ryan; Julie D Saba
Journal:  Invest New Drugs       Date:  2018-01-16       Impact factor: 3.850

4.  Implication of ceramide, ceramide 1-phosphate and sphingosine 1-phosphate in tumorigenesis.

Authors:  Patricia Gangoiti; Maria H Granado; Alicia Alonso; Félix M Goñi; Antonio Gómez-Muñoz
Journal:  Transl Oncogenomics       Date:  2008-04-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.